Added studies in progress propose that ARV-825 might also be effective in enhancing the response to estrogen deprivation (aromatase inhibition), another part of ordinary of treatment in ER+ breast cancer. 88 These preclinical studies provide paradigms for foreseeable future clinical trials in AML